Back to Search
Start Over
Quantitative measurement of HER2 levels by multiplexed mass spectrometry to predict survival in gastric cancer patients treated with trastuzumab
- Source :
- Journal of Clinical Oncology. 33:4050-4050
- Publication Year :
- 2015
- Publisher :
- American Society of Clinical Oncology (ASCO), 2015.
-
Abstract
- 4050 Background: Trastuzumab-based chemotherapy is standard treatment for HER2-positive advanced gastric cancer (AGC). Although increased HER2 gene amplification by fluorescent in situ hybridizatio...
- Subjects :
- Cancer Research
Chemotherapy
Pathology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Standard treatment
Cancer
Advanced gastric cancer
Mass spectrometry
medicine.disease
stomatognathic diseases
Oncology
Trastuzumab
HER2 Gene Amplification
medicine
Cancer research
skin and connective tissue diseases
business
neoplasms
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........c5389e8f822d6f470fc939d46af0dbf0
- Full Text :
- https://doi.org/10.1200/jco.2015.33.15_suppl.4050